Ocular ischemic syndrome: Review of clinical presentations, etiology, investigation, and management

Cella S. Chen, Neil R Miller

Research output: Contribution to journalArticle

Abstract

The ocular ischemic syndrome is a progressive disorder that results from chronic hypoperfusion to the eye and orbit, occurring most often from ipsilateral internal carotid or ophthalmic artery occlusion, or severe stenosis. It may also result from other causes of reduced blood flow to the eye and orbit, such as systemic vasculitis. As such, it is associated with a significant risk of both cardiovascular and cerebrovascular disease. The aim of management is to prevent further ocular damage as well as the secondary prevention of systemic co-morbidities. This review discusses the spectrum of clinical presentations in ocular ischemic syndrome, its etiology, and the current status of both ocular and systemic management.

Original languageEnglish (US)
Pages (from-to)17-28
Number of pages12
JournalComprehensive Ophthalmology Update
Volume8
Issue number1
StatePublished - Jan 2007

Fingerprint

Orbit
Ophthalmic Artery
Cerebrovascular Disorders
Systemic Vasculitis
Internal Carotid Artery
Secondary Prevention
Pathologic Constriction
Cardiovascular Diseases
Morbidity

Keywords

  • Carotid artery occlusion
  • Neovascularization
  • Ocular ischemic syndrome (OIS)
  • Ophthalmic artery vasculitis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ocular ischemic syndrome : Review of clinical presentations, etiology, investigation, and management. / Chen, Cella S.; Miller, Neil R.

In: Comprehensive Ophthalmology Update, Vol. 8, No. 1, 01.2007, p. 17-28.

Research output: Contribution to journalArticle

@article{52a9e974101f47e494704377792899b3,
title = "Ocular ischemic syndrome: Review of clinical presentations, etiology, investigation, and management",
abstract = "The ocular ischemic syndrome is a progressive disorder that results from chronic hypoperfusion to the eye and orbit, occurring most often from ipsilateral internal carotid or ophthalmic artery occlusion, or severe stenosis. It may also result from other causes of reduced blood flow to the eye and orbit, such as systemic vasculitis. As such, it is associated with a significant risk of both cardiovascular and cerebrovascular disease. The aim of management is to prevent further ocular damage as well as the secondary prevention of systemic co-morbidities. This review discusses the spectrum of clinical presentations in ocular ischemic syndrome, its etiology, and the current status of both ocular and systemic management.",
keywords = "Carotid artery occlusion, Neovascularization, Ocular ischemic syndrome (OIS), Ophthalmic artery vasculitis",
author = "Chen, {Cella S.} and Miller, {Neil R}",
year = "2007",
month = "1",
language = "English (US)",
volume = "8",
pages = "17--28",
journal = "Comprehensive Ophthalmology Update",
issn = "1527-7313",
publisher = "Comprehensive Optamology Update LLC.",
number = "1",

}

TY - JOUR

T1 - Ocular ischemic syndrome

T2 - Review of clinical presentations, etiology, investigation, and management

AU - Chen, Cella S.

AU - Miller, Neil R

PY - 2007/1

Y1 - 2007/1

N2 - The ocular ischemic syndrome is a progressive disorder that results from chronic hypoperfusion to the eye and orbit, occurring most often from ipsilateral internal carotid or ophthalmic artery occlusion, or severe stenosis. It may also result from other causes of reduced blood flow to the eye and orbit, such as systemic vasculitis. As such, it is associated with a significant risk of both cardiovascular and cerebrovascular disease. The aim of management is to prevent further ocular damage as well as the secondary prevention of systemic co-morbidities. This review discusses the spectrum of clinical presentations in ocular ischemic syndrome, its etiology, and the current status of both ocular and systemic management.

AB - The ocular ischemic syndrome is a progressive disorder that results from chronic hypoperfusion to the eye and orbit, occurring most often from ipsilateral internal carotid or ophthalmic artery occlusion, or severe stenosis. It may also result from other causes of reduced blood flow to the eye and orbit, such as systemic vasculitis. As such, it is associated with a significant risk of both cardiovascular and cerebrovascular disease. The aim of management is to prevent further ocular damage as well as the secondary prevention of systemic co-morbidities. This review discusses the spectrum of clinical presentations in ocular ischemic syndrome, its etiology, and the current status of both ocular and systemic management.

KW - Carotid artery occlusion

KW - Neovascularization

KW - Ocular ischemic syndrome (OIS)

KW - Ophthalmic artery vasculitis

UR - http://www.scopus.com/inward/record.url?scp=34047219721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047219721&partnerID=8YFLogxK

M3 - Article

C2 - 17394756

AN - SCOPUS:34047219721

VL - 8

SP - 17

EP - 28

JO - Comprehensive Ophthalmology Update

JF - Comprehensive Ophthalmology Update

SN - 1527-7313

IS - 1

ER -